dont compare or looking to CSL, the company is on a level thats beyond the horizon. bigger than the banks.
CSL ipo was $64 only 5 years ago to naw aprox $220 a share.
IXC has alot confidence and achieved alot greatness before the float, but you need to to do alot DD. iv seen it all with bio companies. from trader to investor perspective.
iv only purchase small order half way on IPO day.
Ann: Invex Therapeutics Lists on ASX, page-100
-
- There are more pages in this discussion • 50 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
